Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Sandra Swain, MD, FACP, Georgetown University Medical Center, Washington, DC, discusses the use of trastuzimab deruxtecan for the treatment of HER2+ breast cancer (BC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).